|
| Press Releases |
|
 |
|
| Monday, September 25, 2023 |
|
|
致力于开发中国双抗疗法的生物技术公司武汉友芝友生物于香港联交所主板正式挂牌 |
| 武汉友芝友生物制药股份有限公司（“友芝友生物”、或 “公司”，连同其附属公司，统称“集团”；股份代号：2496.HK），今天上午9时正于香港联合交易所有限公司（“联交所”）主板正式上市并开始买卖。 more info >> |
|
|
致力於開發中國雙抗療法的生物技術公司武漢友芝友生物於香港聯交所主板正式掛牌 |
| 武漢友芝友生物製藥股份有限公司（「友芝友生物」或 「公司」，連同其附屬公司，統稱「集團」；股份代號：2496.HK），今天上午9時正於香港聯合交易所有限公司（「聯交所」）主板正式上市並開始買賣。 more info >> |
|
A biotechnology company dedicated to developing BsAb-based therapies in China, YZY Biopharma Officially Listed on Main Board of SEHK
|
| Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today. more info >> |
|
| Wednesday, September 13, 2023 |
|
|
专注于中国双抗的开发 武汉友芝友生物宣布于港交所主板上市计划 |
| 武汉友芝友生物制药股份有限公司（“友芝友生物”或“公司”，连同其附属公司，统称“集团”；股份代号：2496.HK），一家致力于开发用于治疗癌症相关并发症、癌症及老年性眼科疾病的基于双特异性抗体（双抗）疗法的生物技术公司，今天宣布于香港联合交易所有限公司（“联交所”）主板上市计划。 more info >> |
|
|
專注於中國雙抗的開發 武漢友芝友生物宣佈於港交所主板上市計劃 |
| 武漢友芝友生物製藥股份有限公司（「友芝友生物」或 「公司」，連同其附屬公司，統稱「集團」；股份代號：2496.HK），一家致力於開發用於治療癌症相關併發症、癌症及老年性眼科疾病的基於雙特異性抗體（雙抗）療法的生物技術公司，今天宣佈於香港聯合交易所有限公司（「聯交所」）主板上市計劃。 more info >> |
|
|
Focusing on the development of BsAbs in China, YZY Biopharma Announces Proposed Listing on the Main Board of SEHK |
| Wuhan YZY Biopharma Co., Ltd. ("YZY Biopharma" or the "Company", together with its subsidiaries, the "Group", stock code: 2496.HK), a biotechnology company dedicated to developing bispecific antibody (BsAb)-based therapies to treat cancer-associated complications more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Intellifusion Submits an Application to List on the Hong Kong Stock Exchange: A National Breakthrough in AI Inference Chips
Aug 13, 2025 18:33 HKT/SGT
|
|
|
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Aug 13, 2025 15:33 HKT/SGT
|
|
|
MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth
Aug 13, 2025 15:05 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 15:00: JST
|
|
|
Formerra Becomes North American Distributor for Syensqo PVDF
Aug 13, 2025 14:53 HKT/SGT
|
|
|
GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row
Aug 13, 2025 14:18 HKT/SGT
|
|
|
China Lilang Announces 2025 Interim Results
Aug 13, 2025 14:15 HKT/SGT
|
|
|
Natural Beauty 2025 Interim Profit Surges by 136% to HK$11 Million
Aug 13, 2025 14:13 HKT/SGT
|
|
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT/SGT
|
|
|
74th China (Linyi) International Hardware Expo to Open September 5-7, 2025 in Shandong
Aug 13, 2025 12:00 HKT/SGT
|
|
|
AI Inference vs. AI Training: What Are the Differences?
Aug 13, 2025 11:00 HKT/SGT
|
|
|
Shoucheng Joins World Humanoid Robot Games - 88 Spectators Invited
Aug 13, 2025 10:15 HKT/SGT
|
|
|
首程控股(0697.HK)抽取88位幸運觀眾現場觀賽 深度參與世界人形機器人運動會
Aug 13, 2025 09:58 HKT/SGT
|
|
|
首程控股(0697.HK)抽取88位幸运观众现场观赛 深度参与世界人形机器人运动会
Aug 13, 2025 09:43 HKT/SGT
|
|
|
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
Aug 13, 2025 09:27 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
